Cargando…

Mitochondrial Variations in Non-Small Cell Lung Cancer (NSCLC) Survival

Mutations in the mtDNA genome have long been suspected to play an important role in cancer. Although most cancer cells harbor mtDNA mutations, the question of whether such mutations are associated with clinical prognosis of lung cancer remains unclear. We resequenced the entire mitochondrial genomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhaoxi, Choi, Sojung, Lee, Jinseon, Huang, Yen-Tsung, Chen, Feng, Zhao, Yang, Lin, Xihong, Neuberg, Donna, Kim, Jhingook, Christiani, David C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310616/ https://www.ncbi.nlm.nih.gov/pubmed/25657573 http://dx.doi.org/10.4137/CIN.S13976

Ejemplares similares

Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival
por: Sausville, Lindsay N., et al.
Publicado: (2017)

Predicting Recurrence Using the Clinical Factors of Patients with Non-small Cell Lung Cancer After Curative Resection
por: Lee, Hyun Joo, et al.
Publicado: (2009)

Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
por: Bae, Gab-Yong, et al.
Publicado: (2013)

Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition
por: Choe, Chungyoul, et al.
Publicado: (2015)

Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics
por: Sotgia, Federica, et al.
Publicado: (2017)

Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC
por: Wei, Yongyue, et al.
Publicado: (2018)

Impact on Disease Development, Genomic Location and Biological Function of Copy Number Alterations in Non-Small Cell Lung Cancer
por: Huang, Yen-Tsung, et al.
Publicado: (2011)

Circulating Aneuploid Cells Detected in the Blood of Patients with Infectious Lung Diseases
por: Kim, Hongsun, et al.
Publicado: (2017)

Corrigendum: Circulating Aneuploid Cells Detected in the Blood of Patients with Infectious Lung Diseases
por: Kim, Hongsun, et al.
Publicado: (2017)

ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC)
por: Du, Xue, et al.
Publicado: (2018)

Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development
por: Wang, Zhaoxi, et al.
Publicado: (2009)

Staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2006)

Long‐term survival in locally advanced non‐small cell lung cancer invading the great vessels and heart
por: Park, Byungjoon, et al.
Publicado: (2018)

'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
por: Jefferson, M. F., et al.
Publicado: (1996)

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients
por: Zhai, Ting, et al.
Publicado: (2022)

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Jo, Hyunji, et al.
Publicado: (2022)

Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy
por: Pu, Xia, et al.
Publicado: (2014)

Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival
por: Shen, Sipeng, et al.
Publicado: (2018)

IGDB.NSCLC: integrated genomic database of non-small cell lung cancer
por: Kao, Sen, et al.
Publicado: (2012)

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
por: Satouchi, M, et al.
Publicado: (2007)

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients
por: Rothschild, S.I., et al.
Publicado: (2021)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

ASCO 2020 non-small lung cancer (NSCLC) personal highlights
por: Horvath, Lena, et al.
Publicado: (2021)

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
por: Murphy, Ciara, et al.
Publicado: (2023)

Doxycycline inhibits electric field-induced migration of non-small cell lung cancer (NSCLC) cells
por: Chang, Hui-Fang, et al.
Publicado: (2019)

Prediagnosis Smoking Cessation and Overall Survival Among Patients With Non–Small Cell Lung Cancer
por: Wang, Xinan, et al.
Publicado: (2023)

Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients
por: Lv, Yongbin, et al.
Publicado: (2017)

Role of EIF4G1 network in non‐small cell lung cancers (NSCLC) cell survival and disease progression
por: Del Valle, Luis, et al.
Publicado: (2021)

The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival
por: Schneider, Matthias, et al.
Publicado: (2021)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
por: Tiseo, M, et al.
Publicado: (2010)

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
por: Chien, Chun-Ru, et al.
Publicado: (2012)

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
por: Wald, Ori
Publicado: (2018)

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
por: Fang, Rui, et al.
Publicado: (2018)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Uniportal VATS for Diagnosis and Staging in Non-Small Cell Lung Cancer (NSCLC)
por: Del Campo, Jone Miren, et al.
Publicado: (2023)

Gene-environment interaction effects on lung function- a genome-wide association study within the Framingham heart study
por: Liao, Shu-Yi, et al.
Publicado: (2013)

Correlation between progression‐free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced‐stage EGFR‐mutated non‐small cell lung cancer
por: Lee, Yunkyoung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7cmrcdoi6tgssh9ddmu0leo0hd